Many patients struggle to participate in clinical trials because of the time, cost, and effort burden of travelling to sites. Telemedicine and digital technology offer the means to overcome these key barriers to recruitment and start building novel insights into patient function. Psychiatry stands to benefit from the decentralisation of trials, yet new technologies and new ways of working have yet to be widely adopted.
In efforts to address this disconnect, researchers from Otsuka led a feasibility study into the decentralised clinical trial model for patients with depression, the results of which were recently published in the Journal of Scientific Innovation in Medicine.
In this webinar, experts from Otsuka and Cambridge Cognition will cover:
- Feasibility and acceptability of decentralised trials for patients with depression
- Operational effectiveness and data collection integrity with remote methods
- New insights from automated voice-based testing
- Wider implications of digital technologies for psychiatry
Register for this webinar to learn about the opportunities for implementing decentralised trials in psychiatry.
Speakers
Dr. Francesca Cormack, Director of Research & Innovation, Cambridge Cognition
Francesca Cormack is Director of Research and Innovation at Cambridge Cognition. She has worked to develop and validate novel cognitive testing methodology to support high-frequency, near patient testing using wearable, mobile and voice technology, providing insights into cognitive health in a range of patient groups. Francesca obtained a PhD in Dementia with Lewy Bodies at Newcastle University, followed by post-doctoral and academic positions at University College London and at the Medical Research Council in Cambridge. She is an Honorary Research Fellow at the University of Cambridge Department of Psychiatry and maintains academic collaborations focused on neurological disorders, ageing and psychiatry.
Message Presenter
Dr. Corey Reuteman-Fowler, Director of Global Clinical Development in CNS & Digital Medicine, Otsuka
Dr. Reuteman-Fowler has over 15 years in industry and five years of experience in Clinical Development and Digital Medicine. He specializes in developing new digital technologies that improve medication adherence in serious mental illness resulting in reduced hospitalization and improved patient outcomes. He is also passionate about connecting patients through technology and is responsible for implementing digital technologies in decentralized trials.
Corey received his doctorate degree in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill. Prior to joining Otsuka in 2016, Corey served in various Clinical and Operational roles spanning industry and academia. Presently, he serves as Director in Global Clinical Development in CNS and Digital Medicine at Otsuka Pharmaceuticals & Development Corporation.
Message PresenterWho Should Attend?
Professionals from biotech, pharmaceutical, CRO, healthcare and technology industries who work in:
- Drug development
- Medical affairs
- Clinical operations
- Clinical innovation
- Patient engagement
- Virtual trials
- Digital strategy
- Digital biomarkers
What You Will Learn
- Feasibility and acceptability of decentralised trials for patients with depression
- Operational effectiveness and data collection integrity with remote methods
- New insights from automated voice-based testing
- Wider implications of digital technologies for psychiatry
Xtalks Partner
Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account